Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).

Tuzovic L, Tang S, Miller RS, Rohena L, Shahmirzadi L, Gonzalez K, Li X, LeDuc CA, Guo J, Wilson A, Mills A, Glassberg K, Rotterdam H, Sepulveda AR, Zeng W, Chung WK, Anyane-Yeboa K.

Fetal Diagn Ther. 2015;38(4):296-306. doi: 10.1159/000381638. Epub 2015 May 13.

PMID:
25998219
2.

Complete pathological response in a patient with metastatic esophageal cancer treated with a regimen of capecitabine, oxaliplatin and docetaxel: a case report.

Seetharamu N, Melamed J, Miller G, Rotterdam H, Gonda T, Villanueva G, Halmos B.

J Gastrointest Cancer. 2014 Dec;45 Suppl 1:108-11. doi: 10.1007/s12029-013-9575-6. No abstract available.

PMID:
24415222
3.

Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis.

Navarro Silvera SA, Mayne ST, Gammon MD, Vaughan TL, Chow WH, Dubin JA, Dubrow R, Stanford JL, West AB, Rotterdam H, Blot WJ, Risch HA.

Ann Epidemiol. 2014 Jan;24(1):50-7. doi: 10.1016/j.annepidem.2013.10.009. Epub 2013 Oct 18.

4.

Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer.

Navarro Silvera SA, Mayne ST, Risch HA, Gammon MD, Vaughan T, Chow WH, Dubin JA, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ.

Ann Epidemiol. 2011 Jul;21(7):543-50. doi: 10.1016/j.annepidem.2010.11.019. Epub 2011 Mar 23.

5.

Randomized comparison of 3 different-sized biopsy forceps for quality of sampling in Barrett's esophagus.

Gonzalez S, Yu WM, Smith MS, Slack KN, Rotterdam H, Abrams JA, Lightdale CJ.

Gastrointest Endosc. 2010 Nov;72(5):935-40. doi: 10.1016/j.gie.2010.07.035.

6.

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, Prince MA, Chung WK, Fine RL, Chabot JA, Frucht H.

Clin Cancer Res. 2010 Oct 15;16(20):5028-37. doi: 10.1158/1078-0432.CCR-09-3209. Epub 2010 Sep 28.

7.

RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma.

DiNorcia J, Moroziewicz DN, Ippagunta N, Lee MK, Foster M, Rotterdam HZ, Bao F, Zhou YS, Yan SF, Emond J, Schmidt AM, Allendorf JD.

J Gastrointest Surg. 2010 Nov;14(11):1680-90. doi: 10.1007/s11605-010-1347-z. Epub 2010 Sep 8.

8.

Collagenous sprue is not always associated with dismal outcomes: a clinicopathological study of 19 patients.

Vakiani E, Arguelles-Grande C, Mansukhani MM, Lewis SK, Rotterdam H, Green PH, Bhagat G.

Mod Pathol. 2010 Jan;23(1):12-26. doi: 10.1038/modpathol.2009.151. Epub 2009 Oct 23.

9.

Food group intake and risk of subtypes of esophageal and gastric cancer.

Navarro Silvera SA, Mayne ST, Risch H, Gammon MD, Vaughan TL, Chow WH, Dubrow R, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

Int J Cancer. 2008 Aug 15;123(4):852-60. doi: 10.1002/ijc.23544.

10.

Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.

Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.

Endoscopy. 2007 Dec;39(12):1086-91. Epub 2007 Aug 15.

PMID:
17701854
11.

Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas.

Terry MB, Gammon MD, Zhang FF, Vaughan TL, Chow WH, Risch HA, Schoenberg JB, Mayne ST, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr, Santella RM.

Cancer Causes Control. 2007 Nov;18(9):1039-46. Epub 2007 Jul 31.

PMID:
17665311
12.
13.

Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease.

Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH.

Clin Gastroenterol Hepatol. 2006 Jun;4(6):726-30. Epub 2006 Apr 19.

PMID:
16630760
14.

Carbonated soft drink consumption and risk of esophageal adenocarcinoma.

Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Borchardt L, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

J Natl Cancer Inst. 2006 Jan 4;98(1):72-5.

PMID:
16391374
15.

EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.

Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H.

Gastrointest Endosc. 2005 Jul;62(1):16-23.

PMID:
15990814
16.

Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis.

Memeo L, Jhang J, Hibshoosh H, Green PH, Rotterdam H, Bhagat G.

Mod Pathol. 2005 Aug;18(8):1134-44.

17.

Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers.

Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF, Chow WH.

Clin Gastroenterol Hepatol. 2005 Mar;3(3):225-30.

PMID:
15765441
18.

Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts.

Johnson TC, Diamond B, Memeo L, Negulescu H, Hovhanissyan Z, Verkarre V, Rotterdam H, Fasano A, Caillat-Zucman S, Grosdidier E, Winchester R, Cellier C, Jabri B, Green PH.

Clin Gastroenterol Hepatol. 2004 Oct;2(10):888-94.

PMID:
15476152
19.

Scalloping of duodenal mucosa in Crohn's disease.

Culliford A, Markowitz D, Rotterdam H, Green PH.

Inflamm Bowel Dis. 2004 May;10(3):270-3.

PMID:
15290923
20.

Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy.

Abrams JA, Diamond B, Rotterdam H, Green PH.

Dig Dis Sci. 2004 Apr;49(4):546-50.

PMID:
15185855
21.

EUS-guided trucut needle biopsies in patients with solid pancreatic masses: a prospective study.

Larghi A, Verna EC, Stavropoulos SN, Rotterdam H, Lightdale CJ, Stevens PD.

Gastrointest Endosc. 2004 Feb;59(2):185-90.

PMID:
14745390
22.

Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study.

Gammon MD, Terry MB, Arber N, Chow WH, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Rotterdam H, West AB, Fraumeni JF Jr, Weinstein IB, Hibshoosh H.

Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):34-9.

23.

Population attributable risks of esophageal and gastric cancers.

Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF Jr.

J Natl Cancer Inst. 2003 Sep 17;95(18):1404-13.

PMID:
13130116
24.

Duodenal histology in patients with celiac disease after treatment with a gluten-free diet.

Lee SK, Lo W, Memeo L, Rotterdam H, Green PH.

Gastrointest Endosc. 2003 Feb;57(2):187-91.

PMID:
12556782
25.

Esophagitis dissecans superficialis associated with celiac disease.

Hage-Nassar G, Rotterdam H, Frank D, Green PH.

Gastrointest Endosc. 2003 Jan;57(1):140-1. No abstract available.

PMID:
12518158
26.

Occupation and risk of esophageal and gastric cardia adenocarcinoma.

Engel LS, Vaughan TL, Gammon MD, Chow WH, Risch HA, Dubrow R, Mayne ST, Rotterdam H, Schoenberg JB, Stanford JL, West AB, Blot WJ, Fraumeni JF Jr.

Am J Ind Med. 2002 Jul;42(1):11-22.

PMID:
12111686
27.

Colonoscopy in mice.

Huang EH, Carter JJ, Whelan RL, Liu YH, Rosenberg JO, Rotterdam H, Schmidt AM, Stern DM, Forde KA.

Surg Endosc. 2002 Jan;16(1):22-4. Epub 2001 Oct 13.

PMID:
11961598
28.

Nutrient intake and risk of subtypes of esophageal and gastric cancer.

Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1055-62.

29.

Family history of cancer and risk of esophageal and gastric cancers in the United States.

Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr.

Int J Cancer. 2001 Jul 1;93(1):148-52.

30.

All that scallops is not celiac disease.

Shah VH, Rotterdam H, Kotler DP, Fasano A, Green PH.

Gastrointest Endosc. 2000 Jun;51(6):717-20.

PMID:
10840307
31.

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ.

Cancer Causes Control. 2000 Mar;11(3):231-8.

PMID:
10782657
32.

Pathology of the gastric cardia.

Rotterdam H.

Verh Dtsch Ges Pathol. 1999;83:37-42.

PMID:
10714192
33.

Significance of unsuspected celiac disease detected at endoscopy.

Green PH, Shane E, Rotterdam H, Forde KA, Grossbard L.

Gastrointest Endosc. 2000 Jan;51(1):60-5.

PMID:
10625798
34.

Biopsy diagnosis of colitis: possibilities and pitfalls.

Tsang P, Rotterdam H.

Am J Surg Pathol. 1999 Apr;23(4):423-30.

PMID:
10199471
35.

Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.

Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749-56.

36.

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):97-102.

37.

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.

Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF Jr.

Cancer Res. 1998 Feb 15;58(4):588-90.

38.

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr.

J Natl Cancer Inst. 1998 Jan 21;90(2):150-5.

PMID:
9450576
39.

Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.

Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB.

Cancer Res. 1998 Jan 1;58(1):114-22.

40.

Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorption.

Siegel LM, Stevens PD, Lightdale CJ, Green PH, Goodman S, Garcia-Carrasquillo RJ, Rotterdam H.

Gastrointest Endosc. 1997 Sep;46(3):226-30.

PMID:
9378209
41.

Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr.

J Natl Cancer Inst. 1997 Sep 3;89(17):1277-84.

PMID:
9293918
42.

Primary amyloid tumor of the breast: a case report and review of the literature.

Luo JH, Rotterdam H.

Mod Pathol. 1997 Jul;10(7):735-8. Review.

PMID:
9237186
43.

Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease.

Lynch T, Odel J, Fredericks DN, Louis ED, Forman S, Rotterdam H, Fahn S, Relman DA.

Ann Neurol. 1997 Jul;42(1):120-4.

PMID:
9225695
44.

Gastric sarcoidosis.

Farman J, Ramirez G, Rybak B, Lebwohl O, Semrad C, Rotterdam H.

Abdom Imaging. 1997 May-Jun;22(3):248-52.

PMID:
9107643
45.

Practice guidelines for treatment of peptic ulcer disease.

Tsang P, Rotterdam H.

JAMA. 1996 Oct 9;276(14):1136; author reply 1136-7. No abstract available.

PMID:
8827960
46.

Increased expression of the cyclin D1 gene in Barrett's esophagus.

Arber N, Lightdale C, Rotterdam H, Han KH, Sgambato A, Yap E, Ahsan H, Finegold J, Stevens PD, Green PH, Hibshoosh H, Neugut AI, Holt PR, Weinstein IB.

Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):457-9.

47.

Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.

Megibow AJ, Zhou XH, Rotterdam H, Francis IR, Zerhouni EA, Balfe DM, Weinreb JC, Aisen A, Kuhlman J, Heiken JP, et al.

Radiology. 1995 May;195(2):327-32.

PMID:
7724748
48.

Abdominal manifestations of sarcoidosis. CT appearances.

Farman J, Ramirez G, Brunetti J, Tuvia J, Ng C, Rotterdam H.

Clin Imaging. 1995 Jan-Mar;19(1):30-3.

PMID:
7895193
49.

Gastrointestinal disease in the immunocompromised patient.

Rotterdam H, Tsang P.

Hum Pathol. 1994 Nov;25(11):1123-40. Review.

PMID:
7959657
50.

Gastrointestinal hemorrhage from a Brunner's gland hamartoma.

Schluger LK, Rotterdam H, Lebwohl O.

Am J Gastroenterol. 1994 Nov;89(11):2088-9. No abstract available.

PMID:
7942749

Supplemental Content

Loading ...
Support Center